The development of rongzhi, linked to the future, Chengyu region two-city economic circle pharmaceutical industry integration and development summit forum successfully held!

Introduction: Cooperation and exchange, resource sharing, complementary advantages.
"The large health industry, with medicine and medical care as its leading priority development plans, plays an indispensable role in the construction of the two-city economic circle in Chengyu region."
believe that after the signing of the "Promoting the Integration and Development of the Pharmaceutical Industry and the Industry's Common Governance Strategy Cooperation Agreement" in the Shuangcheng Economic Circle, the Shuangcheng Economic Circle will be better developed.
, " said Deng Wei, head of the Bio-Industry Development Bureau of Chengdu High-tech Zone.
September 10, sponsored by Chengdu High-tech District Bio-Industry Development Bureau, Chongqing South Bank District, the Great Health Industry Development Promotion Center, Chengdu High-tech District Bio-Industry Experts Federation, Chongqing Pharmaceutical Industry Association, Pharmaceutical Intelligence Network co-sponsored the 2020 Health Industry High-Quality Development Conference Sub-Forum - Cheng-Yu Shuangcheng Economic Circle Pharmaceutical Industry Integration and Development Summit Forum held at the Chongqing Marriott Hotel.
Forum Site Chongqing Science and Technology Bureau Deputy Director Xu Zhipeng, Chengdu High-tech District Bio-Industry Development Bureau head Deng Wei, Chongqing South Bank District Health Industry Office Director Fang Ming, Chongqing Medical University School of Pharmacy Party Secretary Feng Tao, Beijing Wanfang Data Co., Ltd. Deputy General Manager, Wanfang Medical Founder Zhang Xiumei and other relevant government leaders, industry association leaders, industry experts, pharmaceutical enterprises, service pharmaceutical companies related business leaders attended the meeting.
People's Network, Xinhuanet, China Net, China News Agency, Guangming Net, International Online, Chongqing Daily, Chongqing Morning Post, Chongqing Evening News, Chengdu Daily, Healthy People's Daily, Hualong.com, Upstream News, Cover News, South Bank Tv, South Bank News, Phoenix Chongqing, Today's headlines, a little information, medical guide, Pharmaceutical Intelligence Media, 36, and other more than 100 public and industry media in Chengdu and Chongqing to carry out national and industry media coverage.
this year, the CPC Central Committee made a major strategic deployment to promote the construction of the two-city economic circle in Chengyu region, which brought great strategic opportunities for Chongqing's reform and opening-up and high-quality development.
, the first meeting of the Joint Meeting of the Party and Government of Chongqing, Sichuan Province, was held to promote the construction of the shuangcheng economic circle in Chengyu region, marking the first time that the construction of the two-city economic circle in Chengyu region has entered the practical stage at the highest level of the two places.
, the General Office of the Sichuan Provincial People's Government and the General Office of the Chongqing Municipal People's Government signed a cooperation agreement on the coordinated promotion of the reform of the two-city economic circle in The Chengdu-Chongqing region.
the two sides will work together to promote the reform of the two-city economic circle in The Yu region, and continue to promote government services for the people, to create a first-class business environment.
Under this beneficial policy, in order to better realize the complementary advantages of the two places, pharmaceutical industry cooperation, sing a good "double city", build a good "economic circle", the pharmaceutical industry as an important growth pole of high-quality development in the west, China Pharmaceutical Research and Development Innovation Summit organizers once again held a discussion on the deep integration and development of the pharmaceutical industry.
meeting site cooperation win-win! At the signing of the strategic agreement between the two places, Deng Wei, head of the Chengdu High-tech District Bio-Industry Development Bureau, said that the pharmaceutical industry is a pillar industry in Chengdu and Chongqing, and pharmaceutical enterprises in both places should seize the opportunity to deepen their interaction and cooperation, while Chengyu region should strengthen coordination and precision in the cultivation of innovative medical talents, provide good development soil for the deep cooperation between enterprises in the two places, and promote the development of the pharmaceutical industry in Chengyu region with high quality.
Dengcheng High-tech District Bio-Industry Development Bureau head Deng Wei, chongqing Science and Technology Bureau Deputy Director Xu Zhipeng expressed the same view in his speech, he pointed out that Chongqing will spare no effort to promote the development of the pharmaceutical industry, industrial scale to promote the improvement of the industrial chain, adopt local-based development policies, and fully support the construction of the two-city economic circle in Chengyu region.
xu Zhipeng, deputy director of Chongqing Science and Technology Bureau, delivered a speech to actively integrate into the construction of the two-city economic circle in Chengyu region, promote the integration and development of the pharmaceutical industry to a new level, Xu Zhipeng, deputy director of the Chongqing Science and Technology Bureau, Deng Wei, head of the Bio-Industry Development Bureau of Chengdu High-tech District, and Fang Ming, director of the Great Health Industry Office of the South Bank District of Chongqing. Witnessed by the Chengdu High-tech District Bio-Industry Experts Federation Secretary-General Ran Wenping, Chongqing Pharmaceutical Industry Association Secretary-General He Ling signed on behalf of the two sides "to promote the integration and development of the pharmaceutical industry in The Chengdu-Yushuangcheng Economic Circle, the industry's strategic cooperation agreement on common governance", on the construction of cooperation and exchange platform, expert think tank resource sharing, and jointly build an industrial service platform and other content to reach consensus.
The signing ceremony was followed by a team of Professor Yang Shengyong of Huaxi Hospital of Sichuan University and representatives of Chongqing Huasen Pharmaceutical Co., Ltd. ("Watson Pharmaceuticals") to sign investment projects to set an example for promoting the integration and development of the pharmaceutical industry in Chengdu and Chongqing.
signed a cooperative investment agreement on the spot! Industry experts Qi qiqi, from Chengyu two places and even the country's dozens of experts and scholars, on-site talk about Chengyu region's two-city economic circle pharmaceutical industry integration and development theme, for how to sing a good "double-city", the construction of "Cheng-Yu economic circle" to make a keynote speech.
Professor Feng Tao, Secretary of the Party Committee of Chongqing Medical University's School of Pharmacy, brought the theme report "Opportunities and Challenges for the Development of Biopharmaceuticals in Chengyu", he said that the development of biopharmaceutical industry in Chengyu region in recent years has attracted much attention, from biomedicine to medical health, to pharmaceutical trade, and the pharmaceutical industry has gradually developed into a world-class, trillion-level pharmaceutical and health industry system.
challenges coexist in this development, how to seize more opportunities and meet the challenges is the most important issue at present.
Tao, Secretary of the Party Committee of Chongqing Medical University's School of Pharmacy, said in a speech on the era of big data, how can medical people scientifically use data to promote the development of enterprises? Dr. Zhang Xiumei, deputy general manager of Beijing Wanfang Data Co., Ltd. and founder of Wanfang Medical, gave a theme report on "Seeing Medicines Like" through Data, noting that in the past five years, China's drug regulatory department has spent the busiest five years, moving towards internationalization, completing docking with ICH, combating data fraud and resolving the backlog of reviews.
Dr. Zhang Xiumei, Deputy General Manager of Beijing Wanfang Data Co., Ltd. and Founder of Wanfang Medical, delivered a keynote speech on "Giant New Drug Seed Bank: First, Best-in-Class New Drug Research and Development Platform" in a speech by Dr. Wu Bo, Chemical Director of Chengdu Pilot Drug Development Co., Ltd., introducing the small molecule discovery method, which lists the targeted compounds and active small molecules that have been screened, and the current success rate has reached 80%.
Dr. Wu Bo, Director of Chemistry, Chengdu Pilot Drug Development Co., Ltd., presented the theme report of "Best Animal Model---- Spontaneous Metabolic Syndrome of Non-Human Primates and Its Complications combined with Medical Imaging" by Professor Wang Wei, Vice President of Four Trump Leme Biotech Group Co., Ltd., who introduced animal models of disease and drug research and development in combination with animal imaging.
4. Professor Wang Wei, Vice President of Trump Lemme Biotech Group Co., Ltd., delivered a speech on the theme of "Innovative Technology System for Drug Non-Clinical Research evaluation" by Dr. Duan Jiachuan, Senior Project Manager, Marketing and Project Management Department, Chengdu Huaxi Haiyan Pharmaceutical Technology Co., Ltd. (National Chengdu New Drug Safety Evaluation Center) In the speech, he pointed out that the global pharmaceutical industry has shown a steady momentum of development, new drug targets and new treatment methods are constantly being discovered and applied, and introduced new drug non-clinical evaluation research new technologies, including molecular and functional imaging research technology platform, drug evaluation system based on insotroviral cells.
Chengdu Huaxi Haiyan Pharmaceutical Technology Co., Ltd. (National Chengdu New Drug Safety Evaluation Center) Senior Project Manager of the Ministry of Marketing and Project Management Dr. Duan Jiachuan speech Chengdu Medical Road Kang Medical Technology Services Co., Ltd. founder, senior engineer Dr. Li Wenjun made a "listing license holder industrialization cooperation platform experience sharing" keynote speech, introduced the listed license holders industrialization cooperation platform experience sharing, and said that the current industrial integration between Chengdu and Chongqing is not enough, industrial integration policy support is very important.
Chengdu Medical Road Kang Medical Technology Services Co., Ltd. founder, senior engineer Dr. Li Wenjun speech Chengdu Haifeng Biotech Co., Ltd. project manager Hu Jia brought the "new drug preclinical public technical services integrated platform" theme report, he said, there is still a lack of drug ability as the core of the CRO institutions, GLP standards to establish service institutions, drug ability evaluation has become the most uncontrollable point and short board of new drug research and development.
Hu Jia, project manager of Chengdu Haifeng Biotech Co., Ltd., gave a presentation by Yu Ling, Commercial Director of Tiger Pharmaceuticals, on the theme of "The Life Cycle Management of Drug Research and Development in WHICH" in which CRO participates, and introduced the contents of drug development, registration evaluation, market use, re-evaluation, etc.
Yu Ling, commercial director of Taige Pharmaceuticals, said in a speech through the experts present that high-quality enterprises face-to-face exchanges, to achieve the deep integration of contacts and enterprise resources, to promote the integration and development of the health industry in Chengyu Shuangcheng.
a round table! The Forum on the Field of Endearing Medicine and Health discussed the topic of "Integration and Development of the Pharmaceutical Industry in Chengyu Shuangcheng Economic Circle", and Fu Zhifeng, Dean of Southwest University College of Pharmacy, Qin Shaorong, Chairman of Taiji Pharmaceutical Research Institute Co., Ltd., Liu Xiaoying, General Manager of Chongqing Huasen Pharmaceutical Co., Ltd., Wu Bo, Chemical Director of Chengdu Pilot Drug Development Co., Ltd., and Lu Yong, General Manager of The Technical Center of Beida Pharmaceutical Co., Ltd., all participated in the round-table forum, which was chaired by Li Tianquan, Vice President of Pharmaceutical Intelligence Network.
round table site Southwest University School of Pharmacy Dean Fu Zhifeng: Sichuan-Yu biomedicine and Jiangsu-Zhejiang gap is obvious, although Cheng-Yu has competition, more is cooperation, hugging group heating is the main theme.
Zhifeng, dean of the School of Pharmacy of Southwest University, expressed his opinion on Taiji Chairman Qin Shaorong: Win-win cooperation, not only Sichuan and Chongqing, the world is now mainly cooperation.
, Chongqing pharmaceutical company Taiji has a large number of talents from Sichuan institutions, with Chengdu Central Hospital University cooperation is numerous, joint project declaration.
, a pro, cooperative development, first of all at the government level, the 14th Five-Year Plan to do a good job in the strategic planning of medicine.
Shaorong, chairman of Chongqing Taiji Pharmaceutical Research Institute Co., Ltd., expressed his opinion on Liu Xiaoying, general manager of Chongqing Huasen Pharmaceutical Co., Ltd.: Cooperation can be win-win.
to establish a two-city economic circle in The Yu region from the regional layout at the national level, and win-win cooperation.
from the pharmaceutical industry's entire industrial chain should also be a win-win cooperation.
Xiaoying, general manager of Chongqing Huasen Pharmaceutical Co., Ltd., expressed his opinion on Wu Bo, chemical director of Chengdu Pilot Drug Development Co., Ltd.: Although cooperation is the main focus, but there is also competition, the first is the competition of talent.
, director of chemistry at Chengdu Pilot Drug Development Co., Ltd., commented on Lu Yongjun, general manager of the technology center of Peking University Pharmaceutical Co., Ltd.: From a big point of view, Cheng Yu is close and cannot be broken.
, chengdu biomedical development has now surpassed Chongqing, Chongqing needs to learn from Chengdu.
, from the industrial help, should also learn from each other.
, Sichuan and Chongqing have a great demand for biomedical talents, but the gap is also very large, increasing the training of talents.
Lu Yong, general manager of the technology center of Peking University Pharmaceutical Co., Ltd., commented on the issue, and the guests discussed the promotion of the pharmaceutical industry in the joint economic circle, the opportunities for cooperation between Cheng and Chongqing, and how the Cheng-Yu Alliance can promote the development of the pharmaceutical industry.
This summit forum, combined with the two-city economic circle construction policy hot spots in Chengyu region, seize the opportunity for the integration and development of the two cities, reach a deep integration of contacts and enterprise resources, through the signing of the strategic agreement between the two pharmaceutical industry associations, to further promote the development and upgrading of the pharmaceutical industry.
future, Chengyu Double City Health Industry will plug in the east wind of policy reform, spread its wings and fly high!